Katalog der Deutschen Nationalbibliothek

Neuigkeiten

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

 
Neuigkeiten Wegen Wartungsarbeiten am Mittwoch, 10. Februar 2026 kann es zwischen 07:30 und 08:30 Uhr zu Unterbrechungen unserer Dienste kommen. // Due to maintenance work on Wednesday, 04 February 2026, there may be interruptions to our services between 07:30 and 08:30.
 
 
 


Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

8911 - 8920 von 9948
<< < > >>


Artikel 8911 Safety and efficacy of tezepelumab vs. placebo in adult patients with severe uncontrolled asthma: a systematic review and meta-analysis
Enthalten in Scientific reports Bd. 12, 3.12.2022, Nr. 1, date:12.2022: 1-13
Online Ressource
Artikel 8912 Safety and Efficacy of Topical Diclofenac Sodium Gel for Knee Osteoarthritis in Elderly and Younger Patients
Enthalten in Drugs & aging Bd. 28, 31.8.2012, Nr. 1, date:1.2011: 27-40
Online Ressource
Artikel 8913 Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study
Enthalten in Stem cell research & therapy Bd. 15, 29.4.2024, Nr. 1, date:12.2024: 1-14
Online Ressource
Artikel 8914 Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
Enthalten in Infectious diseases and therapy Bd. 11, 15.10.2022, Nr. 6, date:12.2022: 2159-2176
Online Ressource
Artikel 8915 Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to determine efficacy
Enthalten in Arthritis Research & Therapy Bd. 16, 30.7.2014, Nr. 4, date:8.2014: 1-3
Online Ressource
Artikel 8916 Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies
Enthalten in Infectious diseases and therapy Bd. 13, 16.12.2023, Nr. 1, date:1.2024: 57-78
Online Ressource
Artikel 8917 Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study
Enthalten in Nature Communications Bd. 16, 5.11.2025, Nr. 1, date:12.2025: 1-9
Online Ressource
Artikel 8918 Safety and Immunogenicity of the ID93 + GLA-SE Tuberculosis Vaccine in BCG-Vaccinated Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
Enthalten in Infectious diseases and therapy Bd. 12, 11.5.2023, Nr. 6, date:6.2023: 1605-1624
Online Ressource
Artikel 8919 Safety and influence of a novel extract of fenugreek on healthy young women: a randomized, double-blinded, placebo-controlled study
Enthalten in Clinical phytoscience Bd. 7, 13.7.2021, Nr. 1, date:12.2021: 1-12
Online Ressource
Artikel 8920 Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults
Enthalten in Scientific reports Bd. 9, 5.7.2019, Nr. 1, date:12.2019: 1-13
Online Ressource


8911 - 8920 von 9948
<< < > >>


E-Mail-IconAdministration